ConductScience.org, home

Paper345448

The treatment of thyroid carcinoma with radioactive iodine.

Beierwaltes WH. Semin Nucl Med, 1978. Cited by 188 papers, by iCite.

Cite this record

ConductScience Library. The treatment of thyroid carcinoma with radioactive iodine. Papers, record 345448. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/345448

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The treatment of thyroid carcinoma with radioactive iodine.
PubMed
Journal
Semin Nucl Med
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
188
iCite
Relative citation ratio, by iCite
8.84
iCite
Revised in PubMed
2019-10-21
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Beierwaltes WHW H

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Iodine RadioisotopesMajor topic
Thyroid NeoplasmsMajor topic
Goiter, Nodular
Humans
Leukemia
Methods
Neoplasm Metastasis
Radionuclide Imaging
Recurrence
Thyroidectomy
Thyrotropin

Source PubMed

Download CSV of topics

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 188 citations.

PMIDTitleJournalYearIn PapersSource
42942330The Use of Radioactive Iodine in the Treatment of Thyroid Cancer: Novel Aspects.Life (Basel)2026https://conductscience.org/library/papers/42942330PubMed
38672667Theranostic Risk Stratification for Thyroid Cancer in the Genomic Paradigm.Cancers (Basel)2024https://conductscience.org/library/papers/38672667PubMed
36699895Effectiveness of mobile robots collecting vital signs and radiation dose rate for patients receiving Iodine-131 radiotherapy: A randomized clinical trial.Front Public Health2022https://conductscience.org/library/papers/36699895PubMed
35885666Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer.Diagnostics (Basel)2022https://conductscience.org/library/papers/35885666PubMed
34773164Incidence rate and factors associated with the development of secondary cancers after radioiodine therapy in differentiated thyroid cancer: a multicenter retrospective study.Eur J Nucl Med Mol Imaging2022https://conductscience.org/library/papers/34773164PubMed
34745257Overexpression of PAX8-AS1 Inhibits Malignant Phenotypes of Papillary Thyroid Carcinoma Cells via miR-96-5p/PKN2 Axis.Int J Endocrinol2021https://conductscience.org/library/papers/34745257PubMed
31772036Mathematical Modeling of Preclinical Alpha-Emitter Radiopharmaceutical Therapy.Cancer Res2020https://conductscience.org/library/papers/31772036PubMed
28775409RADIOIODINE THERAPY FOR DIFFERENTIATED THYROID CARCINOMA : INHS ASVINI EXPERIENCE.Med J Armed Forces India1998https://conductscience.org/library/papers/28775409PubMed
27408836Both F-18 FDG-avidity and Malignant Shape of Cervical Lymph Nodes on PET/CT after Total Thyroidectomy Predict Resistance to High-dose I-131 Therapy in Patients with Papillary Thyroid Cancer.Asia Ocean J Nucl Med Biol2013https://conductscience.org/library/papers/27408836PubMed
25125997Empiric Therapy with Low-Dose I-131 in Differentiated Cancer Thyroid: What is the Magic Number?World J Nucl Med2013https://conductscience.org/library/papers/25125997PubMed
22589604Rational management of differentiated thyroid cancer.Malays J Med Sci2006https://conductscience.org/library/papers/22589604PubMed
21880704The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy.Endocr Rev2011https://conductscience.org/library/papers/21880704PubMed
18697524Anniversary paper: nuclear medicine: fifty years and still counting.Med Phys2008https://conductscience.org/library/papers/18697524PubMed
15517490Current strategies for surgical management and adjuvant treatment of childhood papillary thyroid carcinoma.World J Surg2004https://conductscience.org/library/papers/15517490PubMed
9617595Drug therapy alternatives in the treatment of thyroid cancer.Drugs1998https://conductscience.org/library/papers/9617595PubMed
8449968Contributions of nuclear medicine to the therapy of malignant tumors.J Cancer Res Clin Oncol1993https://conductscience.org/library/papers/8449968PubMed
7441790Follicular carcinoma of the thyroid with metastasis to the breast.J Natl Med Assoc1980https://conductscience.org/library/papers/7441790PubMed
7233950Cancer of the thyroid in youth.World J Surg1981https://conductscience.org/library/papers/7233950PubMed
7183024Anaplastic carcinoma following well-differentiated thyroid cancer: etiological considerations.Yale J Biol Med1982https://conductscience.org/library/papers/7183024PubMed
7175109Comparison of serum thyroglobulin with iodine scans in thyroid cancer.J Endocrinol Invest1982https://conductscience.org/library/papers/7175109PubMed

See all 26 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/345448

GET https://conductscience.org/api/papers/v1/345448/cited_by?page=2